Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Harvard Business School
Federal Trade Commission
Accenture
Healthtrust
Express Scripts
Merck
Chubb
UBS
Farmers Insurance

Generated: August 17, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title: S-timolol hemihydrate treatment process
Abstract:A process for pharmaceutically treating a subject with S-(-)-3-morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazol e hemihydrate comprising preparing a composition containing the hemihydrate and topically applying the prepared composition to a surface of the subject.
Inventor(s): Per alampi; Markku (Kangasala, FI)
Assignee: Leiras OY (Turku, FI)
Filing Date:Oct 11, 1994
Application Number:08/320,327
Claims:1. Process for pharmaceutically treating a subject with S-(-)-3-morpholino-4-(3-tert-butyl-amino-2-hydroxypropoxy)-1,2,5-thiadiazo le hemihydrate comprising the steps of:

preparing a composition containing S-(-)-3-morpholino-4-(3-tert-butyl-amino-2-hydroxypropoxy)-1,2,5-thiadiazo le hemihydrate; and

topically applying the prepared composition to a surface of the subject.

2. The process of claim 1 wherein the step of preparing comprises synthesizing S-(-)-3-morpholino-4-(3-tert-butyl-amino-2-hydroxypropoxy)-1,2,5-thiadiazo le hemihydrate.

3. The process of claim 2 wherein the step of preparing further comprises admixing selected pharmaceutically acceptable adjuvants together with the synthesized S-(-)-3-morpholino-4-(3-tert-butyl-amino-2-hydroxypropoxy)-1,2,5-thiadiazo le hemihydrate.

4. The process of claim 1 wherein the step of preparing comprises forming the composition into an aqueous solution.

5. The process of claim 4 wherein the composition is formed into a dosage form.

6. The process of claim 2 wherein the step of preparing further comprises forming the composition into an aqueous solution.

7. The process of claim 6 wherein the composition is formed into a dosage form.

8. The process of claim 3 wherein the step of preparing further comprises forming the composition into an aqueous solution.

9. The process of claim 8 wherein the composition is formed into a dosage form.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
US Army
Medtronic
Johnson and Johnson
Citi
Colorcon
UBS
Deloitte
US Department of Justice
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot